Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
A Comparison of the Additivity of Brinzolamide Ophthalmic Suspension, 1% (Azopt) and Brimonidine Tartrate Ophthalmic Solution, 0.15% (Alphagan P) to Travoprost Ophthalmic Solution, 0.004% (Travatan) in Patients with Elevated IOP on Travoprost.
Tanna, Angelo P
(PD/PI)
Ophthalmology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
2/1/04
→
9/1/11
Funding
Hermann Eye Fund
(HEF-042/ Agmt 3/29/04)
View all
View less